Thomas Nickel

Summary

Affiliation: Max Planck Institute of Psychiatry
Country: Germany

Publications

  1. ncbi request reprint Clinical and neurobiological effects of tianeptine and paroxetine in major depression
    Thomas Nickel
    Max Planck Institute of Psychiatry, Munich, Germany
    J Clin Psychopharmacol 23:155-68. 2003
  2. ncbi request reprint Treatment with a CRH-1-receptor antagonist (R121919) does not affect weight or plasma leptin concentration in patients with major depression
    Heike E Kunzel
    Max Planck Institute of Psychiatry, Kraepelinstr 2 10, D 80804 Munich, Germany
    J Psychiatr Res 39:173-7. 2005
  3. doi request reprint Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project
    Johannes M Hennings
    Max Planck Institute of Psychiatry, Kraepelinstr 2 10, 80804 Munich, Germany
    J Psychiatr Res 43:215-29. 2009
  4. ncbi request reprint The combined dexamethasone/CRH test as a potential surrogate marker in depression
    Marcus Ising
    Max Planck Institute of Psychiatry, Kraepelinstr 10, D 80804 Munich, Germany
    Prog Neuropsychopharmacol Biol Psychiatry 29:1085-93. 2005
  5. pmc Immunomodulatory effects of aerobic training in obesity
    Thomas Nickel
    Medizinische Klinik und Poliklinik I, Campus Grosshadern, Ludwig Maximilians Universitat Munchen, Munich, Germany
    Mediators Inflamm 2011:308965. 2011
  6. ncbi request reprint Tacrolimus with mycophenolate mofetil or sirolimus compared with calcineurin inhibitor-free immunosuppression (sirolimus/mycophenolate mofetil) after heart transplantation: 5-year results
    Ingo Kaczmarek
    Transplantation Center Munich, Ludwig Maximilians University, Munich, Germany
    J Heart Lung Transplant 32:277-84. 2013
  7. ncbi request reprint Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects
    Heike E Kunzel
    Max Planck Institute of Psychiatry, Kraepelinstr 2 10, D 80804, Munich, Germany
    J Psychiatr Res 37:525-33. 2003
  8. doi request reprint Immunoregulatory effects of the flavonol quercetin in vitro and in vivo
    Thomas Nickel
    Medizinische Klinik und Poliklinik I, Campus Grosshadern, Ludwig Maximilians and University of Munich, 81377, Munich, Germany
    Eur J Nutr 50:163-72. 2011
  9. ncbi request reprint [Gabapentin treatment in a female patient with panic disorder and adverse effects under carbamazepine during benzodiazepine withdrawal]
    Hubertus Himmerich
    Max Planck Institut fur Psychiatrie, Kraepelinstrasse 10, 80804 Munich
    Psychiatr Prax 34:93-4. 2007
  10. ncbi request reprint Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment
    Elisabeth B Binder
    Max Planck Institute of Psychiatry, Kraepelinstr 2 10, 80804 Munich, Germany
    Nat Genet 36:1319-25. 2004

Detail Information

Publications16

  1. ncbi request reprint Clinical and neurobiological effects of tianeptine and paroxetine in major depression
    Thomas Nickel
    Max Planck Institute of Psychiatry, Munich, Germany
    J Clin Psychopharmacol 23:155-68. 2003
    ..The normalization of the HPA system as a common mode of action of different antidepressants seems to be of special interest...
  2. ncbi request reprint Treatment with a CRH-1-receptor antagonist (R121919) does not affect weight or plasma leptin concentration in patients with major depression
    Heike E Kunzel
    Max Planck Institute of Psychiatry, Kraepelinstr 2 10, D 80804 Munich, Germany
    J Psychiatr Res 39:173-7. 2005
    ..Together with previous findings indicating safety, tolerability, and clinical efficacy CRH1R antagonists are highly promising as a new treatment option in depression...
  3. doi request reprint Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project
    Johannes M Hennings
    Max Planck Institute of Psychiatry, Kraepelinstr 2 10, 80804 Munich, Germany
    J Psychiatr Res 43:215-29. 2009
    ..We demonstrated that this subgroup can be characterized by a set of demographic, clinical and neuroendocrine variables allowing to predict unfavorable outcome at an early stage of treatment...
  4. ncbi request reprint The combined dexamethasone/CRH test as a potential surrogate marker in depression
    Marcus Ising
    Max Planck Institute of Psychiatry, Kraepelinstr 10, D 80804 Munich, Germany
    Prog Neuropsychopharmacol Biol Psychiatry 29:1085-93. 2005
    ..Further systematic research is required and already ongoing to confirm the suitability of the combined dex/CRH test as a surrogate marker in depression...
  5. pmc Immunomodulatory effects of aerobic training in obesity
    Thomas Nickel
    Medizinische Klinik und Poliklinik I, Campus Grosshadern, Ludwig Maximilians Universitat Munchen, Munich, Germany
    Mediators Inflamm 2011:308965. 2011
    ..Markers of the innate immune response were investigated in obese (ONE: ET≤40 km/week) and lean athletes (LNE: ET≤40 km/week and LE: ET≥55 km/week)...
  6. ncbi request reprint Tacrolimus with mycophenolate mofetil or sirolimus compared with calcineurin inhibitor-free immunosuppression (sirolimus/mycophenolate mofetil) after heart transplantation: 5-year results
    Ingo Kaczmarek
    Transplantation Center Munich, Ludwig Maximilians University, Munich, Germany
    J Heart Lung Transplant 32:277-84. 2013
    ..This randomized controlled trial was performed to evaluate the efficacy and safety of 3 immunosuppressive protocols...
  7. ncbi request reprint Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects
    Heike E Kunzel
    Max Planck Institute of Psychiatry, Kraepelinstr 2 10, D 80804, Munich, Germany
    J Psychiatr Res 37:525-33. 2003
    ..No effects of R121919 on clinical laboratory parameters including liver enzymes, EEG and ECG were observed. These results encourage the development of other CRH-1-R antagonists as a novel class of antidepressive drugs...
  8. doi request reprint Immunoregulatory effects of the flavonol quercetin in vitro and in vivo
    Thomas Nickel
    Medizinische Klinik und Poliklinik I, Campus Grosshadern, Ludwig Maximilians and University of Munich, 81377, Munich, Germany
    Eur J Nutr 50:163-72. 2011
    ..We aimed to characterize the impact of the flavonol quercetin on DC activity and differentiation in vitro and in vivo...
  9. ncbi request reprint [Gabapentin treatment in a female patient with panic disorder and adverse effects under carbamazepine during benzodiazepine withdrawal]
    Hubertus Himmerich
    Max Planck Institut fur Psychiatrie, Kraepelinstrasse 10, 80804 Munich
    Psychiatr Prax 34:93-4. 2007
    ..Hence, due to their effectiveness and tolerability, newer anticonvulsants could be considered as medication for benzodiazepine withdrawal and as an alternative for benzodiazepine treatment in panic disorders...
  10. ncbi request reprint Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment
    Elisabeth B Binder
    Max Planck Institute of Psychiatry, Kraepelinstr 2 10, 80804 Munich, Germany
    Nat Genet 36:1319-25. 2004
    ..These findings support a central role of genes regulating the HPA axis in the causality of depression and the mechanism of action of antidepressant drugs...
  11. doi request reprint Coronary dilatation after heart transplantation
    Thomas Nickel
    Medizinische Klinik und Poliklinik 1, Campus Großhadern, Ludwig Maximilians Universitat, Munich, Germany
    Transplantation 92:697-702. 2011
    ..2% to 5%. The endothelial-dependent and -independent causes for CD are postulated. So far, the incidence and prognosis of CD after heart transplantation is unknown...
  12. pmc Cell matrix contact modifies endothelial major histocompatibility complex class II expression in high-glucose environment
    Markus Nickmann
    Department of Internal Medicine Cardiology, University Hospital Grosshadern, Ludwig Maximilians University, Munich, Germany
    Am J Physiol Heart Circ Physiol 305:H1592-9. 2013
    ..Increased SOCS expression raises the threshold for IFN-γ to induce HLA-DR expression in a 3-D environment. This immunoprotective effect is maintained even in states of experimental hyperglycemia...
  13. ncbi request reprint Gender-based analysis of outcome after heart transplantation
    Sandra Eifert
    Department for Cardiac Surgery, Ludwig Maximilians University, Munich, Germany
    Exp Clin Transplant 10:368-74. 2012
    ..Literature and registries reveal controversial results. We reviewed 1000 heart transplantations at our center focusing on the influence of gender differences on short- and long-term outcome after heart transplantation...
  14. doi request reprint Magnetic resonance imaging of myocardial injury and ventricular torsion after marathon running
    Henner Hanssen
    Department of Prevention and Sports Medicine, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    Clin Sci (Lond) 120:143-52. 2011
    ..The stress of marathon running seems to be better described as a burden of myocardial overstimulation rather than cardiac injury...
  15. ncbi request reprint Possible case of quetiapine-induced rhabdomyolysis in a patient with depression treated with fluoxetine
    Hubertus Himmerich
    J Clin Psychopharmacol 26:676-7. 2006
  16. doi request reprint Successful treatment of chronic fatigue syndrome with duloxetine and trijodthyronine--a case study
    Marcus C Rosenhagen
    J Clin Psychopharmacol 28:105-7. 2008